SCHEMBL10682425

SCHEMBL10682425

COCC1CNCCN1CC(=O)Nc1c(C)cccc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.42
POLB P06746 1/20 0.42
ALDH1A1 P00352 2/20 0.42
KCNH2 Q12809 2/20 0.40
NFKB1 P19838 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
ADRA1A P35348 1/20 0.40
DRD3 P35462 1/20 0.40
HTR2B P41595 1/20 0.40
SCN5A Q14524 1/20 0.40
LMNA P02545 3/20 0.40
DRD4 P21917 2/20 0.40
KCNK3 O14649 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10680577 0.89 LMNA (0.41) KDM4EALDH1A1KCNH2NFKB1CYP3A4
SCHEMBL10684949 0.87 ALDH1A1 (0.44) KDM4EPOLBALDH1A1KCNH2NFKB1
SCHEMBL11161398 0.84 ALDH1A1 (0.42) KDM4EALDH1A1KCNH2NFKB1CYP3A4
SCHEMBL10680876 0.80 ALDH1A1 (0.43) KDM4EPOLBALDH1A1KCNH2NFKB1
SCHEMBL10682507 0.79 ALDH1A1 (0.44) KDM4EALDH1A1KCNH2CYP3A4CYP2D6
SCHEMBL10679600 0.79 ALDH1A1 (0.43) KDM4EALDH1A1KCNH2NFKB1CYP3A4
SCHEMBL30564541 0.78 CYP3A4 (0.62) KDM4EKCNH2NFKB1CYP3A4CYP2D6
SCHEMBL10682231 0.78 ALDH1A1 (0.42) KDM4EALDH1A1KCNH2NFKB1CYP3A4
SCHEMBL1777934 0.74 ALDH1A1 (0.57) POLBALDH1A1KCNH2NFKB1CYP3A4
SCHEMBL19448262 0.72 MAPT (0.34) KDM4EPOLBALDH1A1CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4766125-A N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia JANSSEN PHARMACEUTICA N.V. (BE) 1988-08-23 US disclosed
EP-0068544-B1 NOVEL N-ARYL-PIPERAZINEALKANAMIDES JANSSEN PHARMACEUTICA N.V. (BE) 1987-06-03 EP disclosed
EP-0068544-A2 Novel N-aryl-piperazinealkanamides JANSSEN PHARMACEUTICA N.V. (BE) 1983-01-05 EP disclosed